Sen. John Boozman sold Eli Lilly and Company (LLY)
Sen. John Boozman (R-AR) · $1K–$15K · traded Nov 21, 2025
- Transaction
- Sold (partial)
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Nov 21, 2025
- Disclosed
- Dec 8, 2025
- Days to disclose
- 17
- Asset type
- Stock
- As filed
- Eli Lilly and Company
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Dec 8, 2025$1K–$15K
Sold (partial) iShares Russell 2000 ETF IWM
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) iShares Core S&P 500 ETF IVV
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) Tortoise North American Pipeline ETF TPYP
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) Vanguard Global ex-U.S. Real Estate ETF VNQI
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) FT Energy Income Partners Enhanced Income ETF EIPI
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) First Trust Global Tactical Commodity Strategy Fund FTGC
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) Vanguard FTSE Developed Markets ETF VEA
$1K–$15K · Traded Nov 21, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) iShares MSCI EAFE ETF EFA
$1K–$15K · Traded Nov 20, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) American Funds New World Fund Class R-6 RNWGX
$1K–$15K · Traded Nov 20, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (partial) Goldman Sachs ActiveBeta Emerging Markets Equity ETF GEM
$1K–$15K · Traded Nov 20, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
$1K–$15K · Traded Nov 13, 2025 · disclosed Dec 8, 2025 · Joint
- Dec 8, 2025$1K–$15K
Sold (full) iShares MSCI All Country Asia ex Japan ETF AAXJ
$1K–$15K · Traded Nov 6, 2025 · disclosed Dec 8, 2025 · Joint
Recent Congress trades in LLY
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Jul 1, 2026 · disclosed Aug 7, 2026
Committee overlap: Energy and Commerce - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Jan 2, 2026 · disclosed Aug 7, 2026 · filed 217 days later
Committee overlap: Energy and Commerce - Aug 7, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Dec 2, 2025 · disclosed Aug 7, 2026 · filed 248 days later
Committee overlap: Energy and Commerce - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Sold (full) Eli Lilly and Company LLY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 17, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 17, 2026 · Spouse
- Jul 2, 2026$50K–$100K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Eli Lilly and Company LLY
$50K–$100K · Traded Jun 10, 2026 · disclosed Jul 2, 2026
- May 13, 2026$1K–$15K
Rep. Byron Donalds (R-FL-19)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Apr 2, 2026 · disclosed May 13, 2026
Company context for LLY
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
LLY: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
LLY: Financial results
Filed 8-K for an event or period dated 2026-10-29. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.